Article
Non-alcoholic steatohepatitis: what can we learn from animal models?
Current medicinal chemistry - 1 Jan 2012
Almonacid-Urrego C C, Sánchez-Campos S, Tuñón M J, González-Gallego J
Abstract excerpt
Non-alcoholic fatty liver disease (NAFLD) is one of the most frequent causes of abnormal liver function and correlates with central adiposity, obesity, insulin resistance, the metabolic syndrome and type 2 diabetes mellitus. The pathological spectrum of NAFLD ranges from fatty liver to non-alcoholic steatohepatitis (NASH), advanced fibrosis, cirrhosis, and even hepatocellular carcinoma. Though NAFLD and NASH are...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
